Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interference

Biochemical Pharmacology

Volumn 83, Issue 1, 2012, Pages 115-121

  Henkel, Arne ^a   Kather, Nicole ^b   Mönch, Bettina ^c   Northoff, Hinnak ^d   Jauch, Johann ^b   Werz, Oliver ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Boswellic acid; Frankincense; Inflammation; Lipopolysaccharide; Nitric oxide synthase; Sepsis

Indexed keywords

ANTIINFLAMMATORY AGENT; BOSWELLIC ACID; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; IN VITRO STUDY; LIMULUS LYSATE TEST; MACROPHAGE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BOSWELLIA; CELL LINE; DIRECTED MOLECULAR EVOLUTION; LIPOPOLYSACCHARIDES; MICE; PLANT EXTRACTS; TRITERPENES;

EID: 81855161738     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.09.026     Document Type: Article

References (58)

1. D. Poeckel, and O. Werz Boswellic acids: biological actions and molecular targets Curr Med Chem 13 2006 3359 3369
2. H.P.T. Ammon Boswellic acids in chronic inflammatory diseases Planta Med 72 2006 1100 1116
3. U. Siemoneit, B. Hofmann, N. Kather, T. Lamkemeyer, J. Madlung, and L. Franke Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids Biochem Pharmacol 75 2008 503 513
4. L. Tausch, A. Henkel, U. Siemoneit, D. Poeckel, N. Kather, and L. Franke Identification of human cathepsin G As a functional target of boswellic acids from the anti-inflammatory remedy frankincense J Immunol 183 2009 3433 3442
5. U. Siemoneit, A. Koeberle, A. Rossi, F. Dehm, M. Verhoff, and S. Reckel Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense Br J Pharmacol 162 2011 147 162
6. H. Safayhi, B. Rall, E.R. Sailer, and H.P. Ammon Inhibition by boswellic acids of human leukocyte elastase J Pharmacol Exp Ther 281 1997 460 463
7. T. Syrovets, B. Büchele, C. Krauss, Y. Laumonnier, and T. Simmet Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases J Immunol 174 2005 498 506
8. T. Syrovets, B. Büchele, E. Gedig, J.R. Slupsky, and T. Simmet Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha Mol Pharmacol 58 2000 71 81
9. B. Büchele, and T. Simmet Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection J Chromatogr B Analyt Technol Biomed Life Sci 795 2003 355 362
10. C. Alexander, and E.T. Rietschel Invited review: bacterial lipopolysaccharides and innate immunity J Endotoxin Res 7 2001 167 202
11. F. Meng, C.A. Lowell, and Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn J Exp Med 185 1997 1661 1670
12. J. Hambleton, S.L. Weinstein, L. Lem, and A.L. DeFranco Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages Proc Natl Acad Sci USA 93 1996 2774 2778
13. E. Andreakos, S.M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, and T. Stonehouse Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP Blood 103 2004 2229 2237
14. J. MacMicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu Rev Immunol 15 1997 323 350
15. R. Salomão, P.S. Martins, M.K.C. Brunialti, M.L. Fernandes, L.S.W. Martos, and M.E. Mendes TLR signaling pathway in patients with sepsis Shock 30 Suppl. 1 2008 73 77
16. R.S. Hotchkiss, and I.E. Karl The pathophysiology and treatment of sepsis New Engl J Med 348 2003 138 150
17. 2+ and differentially interact with platelet-type 12-lipoxygenase Mol Pharmacol 70 2006 1071 1078
18. B. Gayathri, N. Manjula, K.S. Vinaykumar, B.S. Lakshmi, and A. Balakrishnan Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFalpha, IL-1beta, NO and MAP kinases Int Immunopharmacol 7 2007 473 482
19. R.S. Pandey, B.K. Singh, and Y.B. Tripathi Extract of gum resins of Boswellia serrata L. inhibits lipopolysaccharide induced nitric oxide production in rat macrophages along with hypolipidemic property Ind J Exp Biol 43 2005 509 516
20. Y. Takada, H. Ichikawa, V. Badmaev, and B.B. Aggarwal Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression J Immunol 176 2006 3127 3140
21. C. Cuaz-Pérolin, L. Billiet, E. Baugé, C. Copin, D. Scott-Algara, and F. Genze Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/-mice Arterioscler Thromb Vasc Biol 28 2008 272 277
22. J. Jauch, and J. Bergmann An efficient method for the large-scale preparation of 3-O-acetyl-11-oxo-β-boswellic acid and other boswellic acids Eur J Org Chem 475 2003 2 6
23. N. Kather Synthese und Struktur-Wirkungs-Beziehungen von Boswelliasäuren und deren Derivaten. Institut für Organische Chemie II 2007 Universität des Saarlandes Saarbruecken
24. J.L. Ding, and B. Ho A new era in pyrogen testing Trends Biotechnol 19 2001 277 281
25. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55 63
26. R.G. Bogle, A.R. Baydoun, J.D. Pearson, S. Moncada, and G.E. Mann l-Arginine transport is increased in macrophages generating nitric oxide Biochem J 284 1992 15 18
27. D.C. Morrison, and D.M. Jacobs Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides Immunochemistry 13 1976 813 818
28. C. Pellat, Y. Henry, and J.C. Drapier IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between l-arginine-derived nitric oxide and non-heme iron proteins Biochem Biophys Res Commun 166 1990 119 125
29. E.R. Sailer, L.R. Subramanian, B. Rall, R.F. Hoernlein, H.P. Ammon, and H. Safayhi Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity Br J Pharmacol 117 1996 615 618
30. A. Altmann, L. Fischer, M. Schubert-Zsilavecz, D. Steinhilber, and O. Werz Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization Biochem Biophys Res Commun 290 2002 185 190
31. 2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes Br J Pharmacol 141 2004 223 232
32. 2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells J Pharmacol Exp Ther 316 2006 224 232
33. H. Kleinert, P.M. Schwarz, and U. Forstermann Regulation of the expression of inducible nitric oxide synthase Biol Chem 384 2003 1343 1364
34. C. Chen, Y.H. Chen, and W.W. Lin Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages Immunology 97 1999 124 129
35. M. Guha, and N. Mackman LPS induction of gene expression in human monocytes Cell Signal 13 2001 85 94
36. N. Suh, T. Honda, H.J. Finlay, A. Barchowsky, C. Williams, and N.E. Benoit Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages Cancer Res 58 1998 717 723
37. D.J. Gough, K. Sabapathy, E.Y. Ko, H.A. Arthur, R.D. Schreiber, and J.A. Trapani A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes J Biol Chem 282 2007 938 946
38. T. Morikawa, H. Oominami, H. Matsuda, and M. Yoshikawa New terpenoids, olibanumols D-G, from traditional Egyptian medicine olibanum, the gum-resin of Boswellia carterii J Nat Med 65 2011 129 134
39. M. Yoshikawa, T. Morikawa, H. Oominami, and H. Matsuda Absolute stereostructures of olibanumols A, B, C, H, I, and J from olibanum, gum-resin of Boswellia carterii, and inhibitors of nitric oxide production in lipopolysaccharide-activated mouse peritoneal macrophages Chem Pharm Bull (Tokyo) 57 2009 957 964
40. A. Moussaieff, E. Shohami, Y. Kashman, E. Fride, M.L. Schmitz, and F. Renner Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation Mol Pharmacol 72 2007 1657 1664
41. Y.B. Tripathi, M.M. Reddy, R.S. Pandey, J. Subhashini, O.P. Tiwari, and B.K. Singh Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis Inflammopharmacology 12 2004 131 152
42. R. Rylander, B. Bake, J.J. Fischer, and I.M. Helander Pulmonary function and symptoms after inhalation of endotoxin Am Rev Respir Dis 140 1989 981 986
43. O. Michel, J. Duchateau, and R. Sergysels Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects J Appl Physiol 66 1989 1059 1064
44. O. Michel, A.M. Nagy, M. Schroeven, J. Duchateau, J. Nve, and P. Fondu Dose-response relationship to inhaled endotoxin in normal subjects Am J Respir Crit Care Med 156 1997 1157 1164
45. O. Michel, R. Ginanni, B. Le Bon, J. Content, J. Duchateau, and R. Sergysels Inflammatory response to acute inhalation of endotoxin in asthmatic patients Am Rev Respir Dis 146 1992 352 357
46. A. Herbert, M. Carvalheiro, E. Rubenowitz, B. Bake, and R. Rylander Reduction of alveolar-capillary diffusion after inhalation of endotoxin in normal subjects Chest 102 1992 1095 1098
47. O. Michel Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions J Endotoxin Res 9 2003 293 300
48. H. Moshage Nitric oxide determinations: much ado about no-thing? Clin Chem 43 1997 553 556
49. H. Majid, and C. Kao Utility of exhaled nitric oxide in the diagnosis and management of asthma Curr Opin Pulm Med 16 2010 42 47
50. I. Gupta, V. Gupta, A. Parihar, S. Gupta, R. Lüdtke, and H. Safayhi Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study Eur J Med Res 3 1998 511 514
51. G.B. Singh, and C.K. Atal Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent Agents Actions 18 1986 407 412
52. G.K. Reddy, S.C. Dhar, and G.B. Singh Urinary excretion of connective tissue metabolites under the influence of a new non-steroidal anti-inflammatory agent in adjuvant induced arthritis Agents Actions 22 1987 99 105
53. M.L. Sharma, S. Bani, and G.B. Singh Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis Int J Immunopharmacol 11 1989 647 652
54. C. Nathan Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100 1997 2417 2423
55. K. Granfors, S. Jalkanen, O. Mäki-Ikola, R. Lahesmaa-Rantala, R. Saario, and A. Toivanen Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis Lancet 335 1990 685 688
56. H. Gerhardt, F. Seifert, P. Buvari, H. Vogelsang, and R. Repges Therapy of active Crohn's disease with Boswellia serrata extract H15 Z Gastroenterol 39 2001 11 17
57. C.M. Mpofu, B.J. Campbell, S. Subramanian, S. Marshall-Clarke, C.A. Hart, and A. Cross Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease Gastroenterology 133 2007 1487 1498
58. G. Kolios, C. Petoumenos, and A. Nakos Mediators of inflammation: production and implication in inflammatory bowel disease Hepatogastroenterology 45 1998 1601 1609